Clinical Study Data: PIONEER Trials (Oral Semaglutide): PIONEER 1 (Oral Semaglutide vs Placebo): 14 mg oral semaglutide: 4.2 kg (9.3 pounds) average weight loss Placebo: 0.8 kg (1.8 pounds) average weight loss Duration: 26 weeks Conclusion: Modest weight loss, far below injectable results PIONEER 4 (Oral vs Injectable Semaglutide Direct Comparison): 14 mg oral semaglutide daily: 3.7 kg (8.2 pounds) 1.0 mg injectable semaglutide weekly: 5.0 kg (11 pounds) Even at lower injectable dose, injections produced 35% more weight loss Duration: 26 weeks Real-World Effectiveness: Doctors report that real-world results with Rybelsus are often worse than clinical trials because: Adherence Challenges: Must take on empty stomach first thing in morning 30-minute wait before eating or drinking anything else Patients frequently forget or break the rules Each missed or improperly taken dose reduces effectiveness Food Interference: Coffee with oral medication: Dramatically reduces absorption Taking with food: Almost completely prevents absorption Taking with other medications: May interfere with absorption Patient Expectations: Many patients expect oral semaglutide to work as well as injections, leading to disappointment and discontinuation

Tirzepatide also activates GIP receptors, which may improve metabolic response in some patients
Because semaglutide acts on only the GLP-1 receptor (not GIP), some individuals tolerate it better
A study published by Diabetes, Obesity and Metabolism found that users regain most of their lost weight within a year of stopping the medication (Wilding et al.) Either due to the high cost or ongoing shortages, people are seeking alternatives to Ozempic and Wegovy, according to NBC
Available at: Top 10 Hangover Cures.
RT-qPCR was performed with IQ-SYBR Green Supermix (Bio-Rad) with the CFX96 RealTime System (Bio-Rad)